These emerging therapies , Tirzepatide , represent a significant advancement in addressing metabolic dysfunction and potentially related ailments . They all are categorized as GLP-1 pathway agonists , https://rafaelvnbx326843.thechapblog.com/40332277/tirzepatide-a-comprehensive-examination-into-glp-1-compounds